Hyperbaric oxygen should be used for carbon monoxide poisoning.
Br J Clin Pharmacol
; 89(3): 939-941, 2023 03.
Article
em En
| MEDLINE
| ID: mdl-36457237
ABSTRACT
This short review addresses the mechanisms of injury mediated by carbon monoxide (CO) and current information on efficacy of hyperbaric oxygen therapy (HBOT). Recent clinical series involving large, country-wide databases and prospective randomized trials are summarized. We conclude that there is an abundance of basic science and preclinical and clinical research supporting the use of HBOT for acute CO poisoning. With appropriate consideration for pathology and therapeutic mechanisms, HBOT at a dose of 2.5-3.0 atm absolute is a necessary treatment for this toxidrome.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Intoxicação por Monóxido de Carbono
/
Oxigenoterapia Hiperbárica
Tipo de estudo:
Clinical_trials
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article